Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1990-9-5
pubmed:abstractText
Case-control studies have shown that combined oral contraceptives (OCs) are protective against endometrial cancer. In England and Wales, OCs have been on the market for 30 years and widely used for 20 years. Trends in other known risk factors for endometrial cancer would tend to have increased its incidence in that time in women under 55 years of age. Vital statistics however show a decrease for endometrial cancer mortality (41%) and morbidity (15%) in that group. This suggests an important protective effect of OCs on this disease.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0300-5771
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
255-8
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Endometrial cancer trends in England and Wales: a possible protective effect of oral contraception.
pubmed:affiliation
Department of Community Medicine and General Practice, University of Oxford, Radcliffe Infirmary, UK.
pubmed:publicationType
Journal Article